Difference between revisions of "Part:BBa K4361304"
Line 16: | Line 16: | ||
<html> | <html> | ||
<h3>Usage and Biology</h3> | <h3>Usage and Biology</h3> | ||
− | The set of BlcR mutants ( | + | The set of BlcR mutants (</html>[[Part:BBa_K4361300]] through [[Part:BBa_K4361319]]<html>) were expressed in a PURE system in the presence of GreenLys (fluorescent Cy2-labeled lysine). Samples were then run on an SDS PAGE gel (<b>Figure 1.</b>) to determine whether or not the protein was produced. For this mutant (<u>lane 5</u>), it was concluded that the production was not successful due to the bands corresponding to BlcR being too poorly distinguishable. |
<figure> | <figure> |
Revision as of 13:25, 11 October 2022
BlcR A62V
A mutant of the BlcR protein, created through site-directed mutagenesis with primers R7 (Part:BBa_K4361210) and F7.2 A62V (Part:BBa_K4361212). For this mutant, the alanine in position 62 has been changed to valine by mutating the GCG codon to GTG.
This mutant contains no nucleotide substitutions or indels outside of the targeted site.
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 694
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal NgoMIV site found at 78
- 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI.rc site found at 589
Usage and Biology
The set of BlcR mutants (Part:BBa_K4361300 through Part:BBa_K4361319) were expressed in a PURE system in the presence of GreenLys (fluorescent Cy2-labeled lysine). Samples were then run on an SDS PAGE gel (Figure 1.) to determine whether or not the protein was produced. For this mutant (lane 5), it was concluded that the production was not successful due to the bands corresponding to BlcR being too poorly distinguishable.